Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Acer Therapeutics Inc (ACER)

2.78   0.03 (1.09%) 10-23 23:07
Open: 2.75 Pre. Close: 2.75
High: 2.87 Low: 2.72
Volume: 38,419 Market Cap: 33M
Acer Therapeutics, Inc. is a pharmaceutical company. The company is headquartered in Newton, Massachusetts and currently employs 23 full-time employees. The firm is engaged in acquires, develops and intends to commercialize therapies for patients with serious rare diseases with critical unmet medical need. Its late-stage clinical pipeline includes Edsivo (celiprolol) and ACER-001. The firm is developing Edsivo for the treatment of vascular Ehlers-Danlos Syndrome (vEDS) in the United States. The firm is developing ACER-001, a pharmacologic treatment option for the treatment of Maple Syrup Urine Disease (MSUD). ACER-001 is an immediate-release formulation of sodium phenylbutyrate (NaPB) developed using a microencapsulation process. The firm is also developing ACER-001 for the treatment of Urea Cycle Disorders (UCD).

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.871 - 2.889 2.889 - 2.905
Low: 2.68 - 2.7 2.7 - 2.719
Close: 2.749 - 2.779 2.779 - 2.807

Technical analysis

as of: 2020-10-23 4:40:10 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 3.42     One year: 3.87
Support: Support1: 2.32    Support2: 1.93
Resistance: Resistance1: 2.93    Resistance2: 3.31
Pivot: 2.88
Moving Average: MA(5): 2.81     MA(20): 2.89
MA(100): 3.19     MA(250): 3.27
MACD: MACD(12,26):     Signal(9): 0.01
Stochastic oscillator: %K(14,3): 22.40     %D(3): 20.77
RSI: RSI(14): 47.63
52-week: High: 7.25  Low: 1.08  Change(%): -18.0
Average Vol(K): 3-Month: 40493  10-Days: 5198

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ACER has closed above bottom band by 16.9%. Bollinger Bands are 75.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to ACER's normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 15 Oct 2020
SHAREHOLDER ALERT: Schubert Firm Investigating Possible Breaches of Fiduciary Duty by Acer Therapeutics Inc. Officers and Directors - PRNewswire

Fri, 09 Oct 2020
Will Short Term Positive News Increase The Share Price Of Acer Therapeutics Inc. (ACER)? - Invest Million

Thu, 01 Oct 2020
Acer Therapeutics to Present at the Virtual BIO Investor Forum Digital - GlobeNewswire

Thu, 01 Oct 2020
Read This Before Selling Acer Therapeutics Inc. (NASDAQ:ACER) Shares - Yahoo Finance

Wed, 30 Sep 2020
Does Acer Therapeutics Inc (ACER) Have What it Takes to be in Your Portfolio? - InvestorsObserver

Tue, 29 Sep 2020
Do Traders View Acer Therapeutics Inc (ACER) Stock's Current Trend Positively? - InvestorsObserver

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 12
Shares Float (M) 5
% Held by Insiders 24.64
% Held by Institutions 51.93
Shares Short (K) 425
Shares Short P. Month (K) 386

Stock Financials

EPS -2.079
EPS Est This Year -4.870
EPS Est Next Year
Book Value (p.s.) 1.060
Profit Margin
Operating Margin
Return on Assets (ttm) -55.9
Return on Equity (ttm) -109.0
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.783
Qtrly Earnings Growth
Operating Cash Flow (M) -20
Levered Free Cash Flow (M) -13

Stock Valuations

PE Ratio -1.34
PEG Ratio
Price to Book value 2.62
Price to Sales
Price to Cash Flow -1.65

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.